引用本文: | 杨广建, 王燕, 柯娥娥. 曙光乍现,值得期待——pan-HER抑制剂在HER2突变型非小细胞肺癌患者中的疗效及安全性[J]. 循证医学, 2022, 22(4): 202-206. DOI: 10.12019/j.issn.1671-5144.2022.04.003 |
Citation: | YANG Guang-jian, WANG Yan, KE E-e. The Dawn Is Dawing, the Future Is Promising: Efficacy and Safety of pan-HER Inhibitors in Advanced Lung Adenocarcinoma With HER2 Mutations[J]. Journal of Evidence-Based Medicine, 2022, 22(4): 202-206. DOI: 10.12019/j.issn.1671-5144.2022.04.003 |